463 related articles for article (PubMed ID: 8183921)
1. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang Y; Nunes FA; Berencsi K; Furth EE; Gönczöl E; Wilson JM
Proc Natl Acad Sci U S A; 1994 May; 91(10):4407-11. PubMed ID: 8183921
[TBL] [Abstract][Full Text] [Related]
2. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.
Engelhardt JF; Litzky L; Wilson JM
Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095
[TBL] [Abstract][Full Text] [Related]
3. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
Engelhardt JF; Ye X; Doranz B; Wilson JM
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6196-200. PubMed ID: 8016137
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.
Yang Y; Nunes FA; Berencsi K; Gönczöl E; Engelhardt JF; Wilson JM
Nat Genet; 1994 Jul; 7(3):362-9. PubMed ID: 7522742
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.
Yang Y; Li Q; Ertl HC; Wilson JM
J Virol; 1995 Apr; 69(4):2004-15. PubMed ID: 7884845
[TBL] [Abstract][Full Text] [Related]
7. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Xiang Z; Ertl HC; Wilson JM
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7257-61. PubMed ID: 7638177
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
[TBL] [Abstract][Full Text] [Related]
10. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
11. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
12. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
13. The murine cellular immune response to adenovirus type 5.
Müllbacher A; Bellett AJ; Hla RT
Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():31-9. PubMed ID: 2785954
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes.
Steinwaerder DS; Carlson CA; Lieber A
Mol Ther; 2001 Sep; 4(3):211-6. PubMed ID: 11545611
[TBL] [Abstract][Full Text] [Related]
15. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
Yang Y; Ertl HC; Wilson JM
Immunity; 1994 Aug; 1(5):433-42. PubMed ID: 7533647
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
Lieber A; He CY; Kirillova I; Kay MA
J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024
[TBL] [Abstract][Full Text] [Related]
17. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
Sircar S; Rodrigues M; Weber JM
Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
[TBL] [Abstract][Full Text] [Related]
18. E1A and E1B proteins inhibit inflammation induced by adenovirus.
Schaack J; Bennett ML; Colbert JD; Torres AV; Clayton GH; Ornelles D; Moorhead J
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3124-9. PubMed ID: 14976240
[TBL] [Abstract][Full Text] [Related]
19. Efficient Transformation of Primary Human Mesenchymal Stromal Cells by Adenovirus Early Region 1 Oncogenes.
Speiseder T; Hofmann-Sieber H; Rodríguez E; Schellenberg A; Akyüz N; Dierlamm J; Spruss T; Lange C; Dobner T
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795433
[TBL] [Abstract][Full Text] [Related]
20. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
Kim J; Kim JH; Choi KJ; Kim PH; Yun CO
Hum Gene Ther; 2007 Sep; 18(9):773-86. PubMed ID: 17725410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
